Profile

Jim Brown, D.V.M
President and CEO, DURECT

Image of Jim Brown, D.V.M

James E. Brown, D.V.M., co-founded DURECT in 1998 and has served as President, Chief Executive Officer and a Director since June of that year.  DURECT is a publicly-traded specialty pharmaceutical company with two late-stage products in development.  The first of these is REMOXY®, an abuse-deterrent formulation of oxycodone for the treatment of chronic pain, in development by Pfizer.  The second is POSIDUR™ a controlled release formulation of bupivacaine for the treatment of post-operative pain.  DURECT has a number of earlier stage programs as well as two commercial product lines, the ALZET® osmotic mini-pump and LACTEL® Absorbable Polymers

Prior to founding DURECT, Dr. Brown worked at ALZA Corporation as Vice President of Biopharmaceutical and Implant Research and Development. Prior working at ALZA, Dr. Brown held various positions at Syntex Corporation including Director of Business Development, Director of Joint Ventures for Discovery Research, and Program Director for Syntex Research and Development. He began his career in the biopharmaceutical industry working at SYVA, a medical diagnostics company.  He has served on a number of boards including St. Francis High School in Mountain View, California.

Dr. Brown holds a B.A. from San Jose State University and a D.V.M. (Doctor of Veterinary Medicine) from the University of California, Davis where he also conducted post-graduate work in pharmacology and toxicology.

 

Commands

Twitter Feed

Loading tweets...

News Release

UC Davis Graduate School of Management partners with Lawrence Livermore and Sandia National Labs to drive technologies from lab to market

Image of UC Davis Graduate School of Management partners with Lawrence Livermore and Sandia National Labs to drive technologies from lab to market

(Davis, Calif.) – With a joint goal of speeding the transfer of new technologies from the laboratory to the commercial marketplace, the UC Davis Graduate School of Management, Lawrence Livermore National Laboratory and Sandia National Laboratories have announced a new partnership for researchers to develop their entrepreneurial skills.

Spotlight Story

Vickie Sherman MBA 13 Finds Her Passion, Her Career—and Herself

Image of Vickie Sherman MBA 13 Finds Her Passion, Her Career—and Herself

What opportunities, decisions, events have shaped your professional life?

My career path has been a climb across a jungle gym rather than a tangent up a corporate ladder. As a child, I used to thumb through the three-inch JCPenney catalogue, picking out the professional women who I would grow to be. I wanted to rule the world from a corner office in a suit and heels. I wanted to shed my humble origins and become Corporate Barbie.

Spotlight Story

MBA Student Consultants Make an IMPACT
Projects Put Business Needs Front and Center

Image of MBA Student Consultants Make an IMPACT

Agilent Technologies’ Electronic Measurement Group is a $3.6 billion business that over the past decade has seen a dramatic shift in its customer base from U.S., and Western European customers to predominantly Asia-based customers. Today, the majority of the division’s revenues are generated outside of the U.S., with an increasing concentration in China.

Spotlight Story

UC Davis Part-Time MBA in Top 8%, Full-Time MBA in Top 9%
U.S. News & World Report’s latest rankings: This marks the 19th consecutive year our MBA program has been ranked among the best in the nation.

Image of  UC Davis Part-Time MBA in Top 8%, Full-Time MBA in Top 9%

(Davis, CA) — The UC Davis Graduate School of Management’s full-time MBA program has been ranked among the top six percent of AACSB International-accredited programs nationwide, according to U.S. News & World Report’s latest graduate business school rankings released today.